Literature DB >> 18432752

Influenza virus.

R Cottey1, C A Rowe, B S Bender.   

Abstract

This unit contains several methods for infecting mice with influenza virus. It also includes protocols needed to propagate influenza virus in hen eggs, quantitate virus titers (in tissue culture medium and in influenza-infected mouse serum), and adopt human isolates of influenza for growth in mice. Methods for measuring the 50% mouse lethal dose are also included. Finally, protocols for generating anti-influenza cytotoxic T lymphocytes (CTL) from splenocyte precursors and harvesting pulmonary CTL following respiratory tract challenge of mice with influenza virus are provided.

Entities:  

Mesh：

Year:  2001        PMID： 18432752     DOI： 10.1002/0471142735.im1911s42

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN： 1934-3671


  41 in total

1.  Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.

Authors:  William C Weldon; Maria P Martin; Vladimir Zarnitsyn; Baozhong Wang; Dimitrios Koutsonanos; Ioanna Skountzou; Mark R Prausnitz; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

2.  Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers.

Authors:  Robert M Jacobson; Diane E Grill; Ann L Oberg; Pritish K Tosh; Inna G Ovsyannikova; Gregory A Poland
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Migration of the swine influenza virus δ-cluster hemagglutinin N-linked glycosylation site from N142 to N144 results in loss of antibody cross-reactivity.

Authors:  Ben M Hause; Douglas L Stine; Zizhang Sheng; Zhao Wang; Suvobrata Chakravarty; Randy R Simonson; Feng Li
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

4.  Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity.

Authors:  Yasushi Uematsu; Michael Vajdy; Ying Lian; Silvia Perri; Catherine E Greer; Harold S Legg; Grazia Galli; Giulietta Saletti; Gillis R Otten; Rino Rappuoli; Susan W Barnett; John M Polo
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

5.  Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets.

Authors:  Krista M McCutcheon; Julia Gray; Natalie Y Chen; Keyi Liu; Minha Park; Stote Ellsworth; Ralph A Tripp; S Mark Tompkins; Scott K Johnson; Shelly Samet; Lenore Pereira; Lawrence M Kauvar
Journal:  MAbs       Date:  2014-01-08       Impact factor: 5.857

6.  Limited replication of influenza A virus in human mast cells.

Authors:  Candy W Marcet; Chris D St Laurent; Tae Chul Moon; Nav Singh; A Dean Befus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

7.  A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.

Authors:  Alison Han; Lindsay M Czajkowski; Amanda Donaldson; Holly Ann Baus; Susan M Reed; Rani S Athota; Tyler Bristol; Luz Angela Rosas; Adriana Cervantes-Medina; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

8.  Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.

Authors:  Jessica M Breslow-Deckman; Cynthia M Mattingly; Susan E Birket; Samantha N Hoskins; Tam N Ho; Beth A Garvy; David J Feola
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

9.  Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection.

Authors:  Kyra D Zens; Jun Kui Chen; Donna L Farber
Journal:  JCI Insight       Date:  2016-07-07

10.  Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture.

Authors:  John S Sullivan; Paul W Selleck; Teena Downton; Ingrid Boehm; Anna-Maree Axell; Yasmin Ayob; Natalie M Kapitza; Wayne Dyer; Anna Fitzgerald; Bradley Walsh; Garry W Lynch
Journal:  J Mol Genet Med       Date:  2009-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.